Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

WRAPUP 4-Pacific trade ministers vow to reach deal but extra time needed

Published 2015-10-01, 09:52 p/m
© Reuters.  WRAPUP 4-Pacific trade ministers vow to reach deal but extra time needed

(Adds details on debate over biologics, Amari comment on
biologics)
By Ana Isabel Martinez and Kevin Krolicki
ATLANTA, Oct 1 (Reuters) - Trade ministers from a dozen
Pacific nations meeting in Atlanta extended talks on a sweeping
trade deal until Saturday in a bid to get a final agreement on
the most ambitious trade pact in a generation.
Officials extended talks originally scheduled to wrap up on
Thursday in a determined effort to produce a breakthrough on the
Trans-Pacific Partnership, which would liberalize trade in 40
percent of the world economy for a region stretching from
Vietnam to Canada.
"No one wants to leave without an agreement," Mexican
Economy Minister Ildefonso Guajardo told Reuters after a second
plenary session of top officials from all 12 nations. "The good
news is that we will not leave here without one."
Observers pointed to progress on autos, Canada's pledge to
compensate farmers hurt by imports and signs of a possible
compromise on patent protection for new drugs as evidence of
advancement - although that remained a key sticking point.
"We are starting to see the path to an agreement and have
agreed to make final efforts," Japanese Economy Minister Akira
Amari told reporters.
Several officials said a final deal could come quickly
depending on the outcome of bilateral talks on intellectual
property protection for medicines and trade in dairy and autos.
Amari said the monopoly period for biologic drugs, which are
made from living cells, was the most difficult issue remaining.
TPP countries have protection periods ranging from 12 years in
the United States to five years in countries including Australia
and Chile.
A deal would be a legacy-defining achievement for U.S.
President Barack Obama. But the trade deal is seen as a threat
by an array of interest groups from Mexican auto workers to
Quebec dairy farmers to cancer patients who worry that it could
push the cost of new therapies out of reach.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

CONGRESSIONAL CONCERNS
In a reassertion of concern in Congress, a group of U.S.
lawmakers from both parties sent a letter to U.S. Trade
Representative Michael Froman and Treasury Secretary Jack Lew on
Wednesday.
"We urge you to take the time necessary to get the best deal
possible for the United States, working closely with us," said
the letter signed by House Ways and Means Committee Chairman
Paul Ryan and Senate Finance Committee Chairman Orrin Hatch as
well as the senior Democrats on those two committees.
Several Republicans attacked a new U.S. proposal to ensure
governments would be free to enact anti-smoking measures without
fear of legal action by tobacco companies.
That could prevent companies like Philip Morris PM.N and
Japan Tobacco Inc 2914.T from using rules to protect foreign
investors to challenge public health measures but falls short of
the sweeping measure anti-smoking groups had hoped for.
Guajardo said talks on auto trade had progressed but were
not over yet.
The auto issue is crucial for Japan, whose automakers, led
by Toyota Motor Corp 7203.T , depend on sales to the U.S.
market and want flexibility on sourcing auto parts.
But Mexico, which has experienced a boom in auto-related
investment over the last two decades, wants to protect its
manufacturers against increased competition from Asia.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.